<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:18:03Z</responseDate>
  <request identifier="oai:figshare.com:article/34034752" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034752</identifier>
        <datestamp>2026-09-30T17:40:07Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist.&lt;/p&gt;</dc:title>
          <dc:creator>Maryam Ghadimi (9714725)</dc:creator>
          <dc:creator>Housne Begum (17364233)</dc:creator>
          <dc:creator>Dena Zeraatkar (3939671)</dc:creator>
          <dc:creator>Jinhui Ma (288674)</dc:creator>
          <dc:creator>Sobha Sivaprasad (318118)</dc:creator>
          <dc:creator>Enrico Borrelli (750198)</dc:creator>
          <dc:creator>Peter Kaiser (11590)</dc:creator>
          <dc:creator>David H. Steel (12027503)</dc:creator>
          <dc:creator>Tien Yin Wong (6873233)</dc:creator>
          <dc:creator>Robyn Guymer (3457265)</dc:creator>
          <dc:creator>Charles C. Wykoff (8550325)</dc:creator>
          <dc:creator>Varun Chaudhary (37352)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>systematically searched medline</dc:subject>
          <dc:subject>ocular adverse events</dc:subject>
          <dc:subject>low luminance bcva</dc:subject>
          <dc:subject>ischemic optic neuropathy</dc:subject>
          <dc:subject>interpret findings using</dc:subject>
          <dc:subject>interest include best</dc:subject>
          <dc:subject>corrected visual acuity</dc:subject>
          <dc:subject>conduct frequentist random</dc:subject>
          <dc:subject>adverse events leading</dc:subject>
          <dc:subject>mean macular sensitivity</dc:subject>
          <dc:subject>geographic atrophy secondary</dc:subject>
          <dc:subject>bcva ), untransformed</dc:subject>
          <dc:subject>slow ga progression</dc:subject>
          <dc:subject>independently screen studies</dc:subject>
          <dc:subject>related macular degeneration</dc:subject>
          <dc:subject>living systematic review</dc:subject>
          <dc:subject>bilateral ga secondary</dc:subject>
          <dc:subject>amd ), leads</dc:subject>
          <dc:subject>analysis &lt;/ p</dc:subject>
          <dc:subject>ga secondary</dc:subject>
          <dc:subject>ga ),</dc:subject>
          <dc:subject>macular neovascularization</dc:subject>
          <dc:subject>related quality</dc:subject>
          <dc:subject>many studies</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>w4jhr &lt;/</dc:subject>
          <dc:subject>standard care</dc:subject>
          <dc:subject>square root</dc:subject>
          <dc:subject>rescue treatment</dc:subject>
          <dc:subject>reading speed</dc:subject>
          <dc:subject>paired reviewers</dc:subject>
          <dc:subject>ophthoevidence report</dc:subject>
          <dc:subject>numerous trials</dc:subject>
          <dc:subject>network meta</dc:subject>
          <dc:subject>legal blindness</dc:subject>
          <dc:subject>grade approach</dc:subject>
          <dc:subject>extract data</dc:subject>
          <dc:subject>evaluated interventions</dc:subject>
          <dc:subject>date summary</dc:subject>
          <dc:subject>comparative benefits</dc:subject>
          <dc:subject>cochrane central</dc:subject>
          <dc:subject>available interventions</dc:subject>
          <dc:subject>approximately 16</dc:subject>
          <dc:subject>advanced form</dc:subject>
          <dc:description>&lt;p&gt;PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:40:04Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1371/journal.pone.0358699.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/_p_PRISMA-P_Preferred_Reporting_Items_for_Systematic_review_and_Meta-Analysis_Protocols_2015_checklist_p_/34034752</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
